AZD0486 Shows Good Efficacy in Relapsed/Refractory Follicular Lymphoma

Published Date: 03 Jan 2025

Novel CD19xCD3 T-cell engager showed high response rate in phase I study

Read Full News

Latest News


News All Time

Featured News
Featured Articles
Featured Events
Featured KOL Videos

1.

'The Pitt' Actor's Cancer Diagnosis; New HHS Research Plans; Madonna Reveals Injury

2.

Inside the Major Findings From the NHS-Galleri Trial

3.

A single bout of exercise gives results that could help cancer patients

4.

Clinical trial results show low-intensity therapy can achieve positive outcomes for certain pediatric leukemia subtypes

5.

Train Eyes so Myopia Doesn't Get Worse? Nurse Intervention for BP Post-Stroke


© Copyright 2026 Hidoc Dr. Inc.

Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation
bot